# US 2013/0251808 A1 · Pharmaceutical composition, method of preparation and methods of treating aches/pains

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0251808 A1
- Document ID: US20130251808A1
- Status: Published application
- Kind: A1
- Application number: 13/898,130
- Filed: 2013-05-20
- Published: 2013-09-26
- Earliest claimed: 2008-05-07
- Inventors: Nicholas DeSica; Muhammed Ali; Richard Li
- Web page: https://patentgrep.com/patent/US20130251808A1

## CPC

- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 9/006: {Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays}
- A61K 31/192: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)}
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/183: {Amino acids, e.g. glycine, EDTA or aspartame}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Provided are methods and compositions useful for treating/aches and/or pains. The composition includes ibuprofen and arginine in a clear stable aqueous ethanol vehicle that is stable at room temperature for at least 6 months without separation or precipitation. The composition is effective for delivering ibuprofen directly through the mucosal or buccal tissue without passing through the GI tract.

## Claims

### Claim 1

A stable aqueous ibuprofen composition comprising:
ibuprofen;
glycerin;
arginine in an amount sufficient to enhance the solubility of said ibuprofen and stabilize said composition;
ethanol; and
the balance water;
said stable aqueous ibuprofen composition having a pH of about 7.0-8.0, and where said composition is a clear composition having said ibuprofen dissolved in solution and dispersed in suspension and having a particle size of 500 nm or less.

### Claim 2 (depends on 1)

The composition of claim 1, further comprising
a sweetener, and
a flavoring agent.

### Claim 3 (depends on 2)

The composition of claim 2, further comprising
a mucosal permeation enhancing agent comprising a mixture of polysorbate, Tween20 and potassium sorbate.

### Claim 4 (depends on 1)

The composition of claim 1, wherein
said composition is obtained by a method comprising the step of
forming an ibuprofen-ethanol solution,
forming a first mixture of water, glycerine, sodium chloride and an emulsifier,
adding the ibuprofen-ethanol solution to the first mixture and mixing under vacuum of 10-14 psi and under high shear to form a second mixture,
adding said buffering agent to said second mixture and mixing under vacuum and high shear to obtain a third mixture, and
filtering the third mixture through a 10 micron filter to obtain said stable aqueous ibuprofen composition.

### Claim 5 (depends on 1)

The composition of claim 1, further comprising
feverfew and ginger extract.

### Claim 6 (depends on 1)

The composition of claim 1, further comprising
sucralose.

### Claim 7 (depends on 1)

The composition of claim 1, further comprising
said emulsifier is selected from the group consisting of azone, sodium glycholate, sodium cholate, sodium taurocholate, sodium taurocholate plus EDTA, deoxycholate, sodium lauryl sulfate, lauric acid, ethanol, lysophosphatidyl choline, polysorbate, cyclodextrin, cetylpyridinium chloride, cetyltrimethylammonium bromide, benzalkonium chloride, sodium salicylate, sodium EDTA, aprotinin, dextran sulfate, linoleic acid, labrafil, transcutol, urea, methoxysalicylate, POE 23 lauryl ether.

### Claim 8 (depends on 7)

The composition of claim 7, wherein
said emulsifier is a mixture of lecithin, polysorbate and Tween20.

### Claim 9

A stable aqueous sublingual pharmaceutical composition obtained by a process, comprising the steps of:
mixing ibuprofen powder in a mixture comprising water, alcohol and glycerin to form a first ibuprofen mixture;
preparing a second mixture of salt, sugar, an emulsifier, arginine and a preservative in water and glycerin and mixing under vacuum of 10-14 psi and high shear; and
thereafter mixing said first ibuprofen mixture and said second mixture under vacuum of 10-14 psi and high shear to produce said stable aqueous pharmaceutical composition wherein the ibuprofen in said stable pharmaceutical composition has a particle size of 500 nanometers or less.

### Claim 10 (depends on 9)

The composition according to claim 9, wherein said mixture of salt, sugar and preservative in water and glycerin further comprises lecithin, polysorbate or a combination thereof.

### Claim 11 (depends on 9)

The composition according to claim 9, further comprising the step of adding flavors, arginine or a combination thereof to said aqueous stable pharmaceutical composition and mixing under vacuum of 10-14 psi and high shear for about 5-15 minutes, and wherein said aqueous sublingual spray composition has a pH of about 7.0 to 8.0.

### Claim 12 (depends on 9)

The composition according to claim 9, further comprising the step of filtering the resulting pharmaceutical composition through a filtration assembly having an opening of about 10 microns.

### Claim 13

A method of treating pain in a patient in need thereof comprising
administering an aqueous ibuprofen composition directly to the sublingual or buccal tissue of a patient in an amount to deliver ibuprofen to the bloodstream, said ibuprofen composition being a stable, clear composition having ibuprofen in solution and/or suspension and where said ibuprofen has a particle size of about 500 nm or less.

### Claim 14 (depends on 13)

The method of claim 13, wherein said ibuprofen composition is formed by:
dissolving in a first container ibuprofen USP grade powder in a succession manner according to HPUS with a dissolution solution of water, alcohol, and glycerin forming an ibuprofen solution;
dissolving in a second container salt, sugar and at least one preservative in a solution of having water, glycerin and arginine in a vacuum equipped vessel under a high shear mixing to form a mixture; and
combining said ibuprofen solution and mixture and mixing in a vacuum equipped vessel under a high shear mixing to form said ibuprofen composition, wherein the particle size is less than or equal to 500 nanometers.
